Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China flag China · Delayed Price · Currency is CNY
51.46
+2.58 (5.28%)
Feb 3, 2026, 3:00 PM CST

SHA:688091 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
22.966.98161.55142.85-4-21.85
Depreciation & Amortization
11.1611.167.886.436.596.17
Other Amortization
0.70.70.3-0.560.97
Loss (Gain) From Sale of Assets
-----0
Asset Writedown & Restructuring Costs
-----0.71
Loss (Gain) From Sale of Investments
-9.69-9.69-7.52-12.89-5.44-4.25
Provision & Write-off of Bad Debts
-5.06-5.065.432.030.22-
Other Operating Activities
-71.25-12.97-26.94-18.33-5.81-2.27
Change in Accounts Receivable
8585-69.19-28.46-21.5-0.56
Change in Inventory
-16.73-16.73-11.38-5.28-10.31.25
Change in Accounts Payable
-17.4-17.430.4217.72-3.81-0.38
Operating Cash Flow
-2.8539.4486.55110.78-48.78-20.21
Operating Cash Flow Growth
--54.44%-21.87%---
Capital Expenditures
-134.49-80.04-8.78-35.88-3.14-5
Sale of Property, Plant & Equipment
-0.010---0
Investment in Securities
-135-13586511.29-788.7416.12
Other Investing Activities
-311.7922.3939.2726.866.255.88
Investing Cash Flow
-581.28-192.65116.49502.27-785.6317
Short-Term Debt Issued
-9.144-16.753.25
Total Debt Issued
-9.144-16.753.25
Short-Term Debt Repaid
--53.1--16.75-3.25-
Total Debt Repaid
-10.9-53.1--16.75-3.25-
Net Debt Issued (Repaid)
-10.9-4444-16.7513.53.25
Issuance of Common Stock
21.3618.77--1,008-
Repurchase of Common Stock
-37.24-37.24----
Common Dividends Paid
-0.01-49.79-43.41-0.49--
Other Financing Activities
27.94----76.59-
Financing Cash Flow
1.15-112.270.59-17.24944.653.25
Net Cash Flow
-582.99-265.48203.64595.82110.240.04
Free Cash Flow
-137.34-40.677.7774.9-51.93-25.22
Free Cash Flow Growth
--3.83%---
Free Cash Flow Margin
-55.59%-23.40%21.59%31.74%-1273.49%-
Free Cash Flow Per Share
-0.59-0.170.490.36-0.33-0.17
Cash Interest Paid
----0.59-
Cash Income Tax Paid
2.6423.8932.97-0.880.49-0.15
Levered Free Cash Flow
-92.54-30.355.2233.72-50.68-15.38
Unlevered Free Cash Flow
-92.54-29.8655.3933.72-50.31-15.38
Change in Working Capital
48.3248.32-54.15-9.31-40.90.31
Source: S&P Global Market Intelligence. Standard template. Financial Sources.